339 related articles for article (PubMed ID: 11256332)
21. [Adjuvant therapy of malignant melanoma].
Hauschild A; Volkenandt M
Ther Umsch; 1999 Jun; 56(6):324-9. PubMed ID: 10420815
[TBL] [Abstract][Full Text] [Related]
22. Advances in melanoma therapy.
Johnson TM; Yahanda AM; Chang AE; Fader DJ; Sondak VK
J Am Acad Dermatol; 1998 May; 38(5 Pt 1):731-41. PubMed ID: 9591818
[TBL] [Abstract][Full Text] [Related]
23. Current therapy for malignant melanoma.
Legha SS
Semin Oncol; 1989 Feb; 16(1 Suppl 1):34-44. PubMed ID: 2465575
[TBL] [Abstract][Full Text] [Related]
24. Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology Group.
Agarwala SS; Neuberg D; Park Y; Kirkwood JM
Cancer; 2004 Apr; 100(8):1692-8. PubMed ID: 15073858
[TBL] [Abstract][Full Text] [Related]
25. Malignant melanoma: non-metastatic.
Crosby D; Crosby T; Mason M
Clin Evid; 2002 Jun; (7):1519-29. PubMed ID: 12230768
[No Abstract] [Full Text] [Related]
26. A randomized trial of adjuvant chemotherapy and immunotherapy in Stage I and Stage II cutaneous melanoma. An interim report.
Sterchi JM; Wells HB; Case LD; Spurr CL; White DR; Richards F; Muss HB; Jackson DV; Stuart JJ; Cooper MR
Cancer; 1985 Feb; 55(4):707-12. PubMed ID: 3967167
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant chemotherapy and immunotherapy in high risk patients with melanoma.
El-Domeiri AA; Das Gupta TK; Trippon M; Simo C; Sabet TY; Crispen R
Surg Gynecol Obstet; 1978 Feb; 146(2):230-2. PubMed ID: 622668
[TBL] [Abstract][Full Text] [Related]
28. Does adjuvant vaccine therapy really have activity in malignant melanoma?
Wheatley K; Ives NJ; Lorigan P
J Clin Oncol; 2007 Oct; 25(29):4693; author reply 4693-5. PubMed ID: 17925569
[No Abstract] [Full Text] [Related]
29. Adjuvant therapy for high-risk primary and resected metastatic melanoma.
Hersey P
Intern Med J; 2003; 33(1-2):33-43. PubMed ID: 12534876
[TBL] [Abstract][Full Text] [Related]
30. [Adjuvant interferon-alpha therapy of malignant melanoma. Position of the Dermatologic Oncology Working Group].
Hauschild A; Dummer R; Garbe C; Kaufmann R; Schadendorf D; Soyer HP; Stadler R; Tilgen W
Hautarzt; 1998 Mar; 49(3):167-9. PubMed ID: 9565782
[No Abstract] [Full Text] [Related]
31. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.
Gutterman JU; Mavligit GM; Reed R; Burgess MA; Gottlieb J; Hersh EM
Cancer Treat Rep; 1976 Feb; 60(2):177-82. PubMed ID: 769970
[TBL] [Abstract][Full Text] [Related]
32. Metastatic melanoma.
Sun W; Schuchter LM
Curr Treat Options Oncol; 2001 Jun; 2(3):193-202. PubMed ID: 12057119
[TBL] [Abstract][Full Text] [Related]
33. Malignant melanoma--future prospects.
Lugović L; Situm M; Kos L
Acta Dermatovenerol Croat; 2005; 13(1):36-43. PubMed ID: 15788145
[TBL] [Abstract][Full Text] [Related]
34. A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma.
Veronesi U; Adamus J; Aubert C; Bajetta E; Beretta G; Bonadonna G; Bufalino R; Cascinelli N; Cocconi G; Durand J; De Marsillac J; Ikonopisov RL; Kiss B; Lejeune F; MacKie R; Madej G; Mulder H; Mechl Z; Milton GW; Morabito A; Peter H; Priario J; Paul E; Rumke P; Sertoli R; Tomin R
N Engl J Med; 1982 Oct; 307(15):913-6. PubMed ID: 7050717
[TBL] [Abstract][Full Text] [Related]
35. Quality-of-life-adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: an Eastern Cooperative Oncology Group study.
Cole BF; Gelber RD; Kirkwood JM; Goldhirsch A; Barylak E; Borden E
J Clin Oncol; 1996 Oct; 14(10):2666-73. PubMed ID: 8874325
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant therapy of stage IIIb melanoma with interferon alfa-2b: clinical and immunological relevance.
Doveil GC; Fierro MT; Novelli M; Appino A; Bertero M; Quaglino P; Bernengo MG
Dermatology; 1995; 191(3):234-9. PubMed ID: 8534942
[TBL] [Abstract][Full Text] [Related]
37. [Current results with surgery and adjuvant chemotherapy in malignant melanoma].
Mechl Z; Kopecný J
Arch Geschwulstforsch; 1986; 56(5):367-71. PubMed ID: 2429631
[TBL] [Abstract][Full Text] [Related]
38. Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial.
Eggermont AM; Suciu S; MacKie R; Ruka W; Testori A; Kruit W; Punt CJ; Delauney M; Sales F; Groenewegen G; Ruiter DJ; Jagiello I; Stoitchkov K; Keilholz U; Lienard D;
Lancet; 2005 Oct; 366(9492):1189-96. PubMed ID: 16198768
[TBL] [Abstract][Full Text] [Related]
39. [Results in the use of immunochemotherapy in patients with cutaneous malignant melanoma].
Calbo L; Gorgone S; Palmeri R; Salibra M; Melita P
Chir Ital; 1983 Aug; 35(4):519-25. PubMed ID: 6680859
[TBL] [Abstract][Full Text] [Related]
40. [Current aspects in the treatment of malignant melanoma].
Barth A; Cerny T
Schweiz Med Wochenschr; 1994 Sep; 124(36):1592-603. PubMed ID: 7939527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
